Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 251 clinical trials
Featured trial
Atopic Dermatitis or Eczema

This study is to see how safe and effective the topical spray on trial medication is when used on subjects with Pruritus or Itch with Atopic Dermatitis

topical agents
  • 2 views
  • 29 Jul, 2021
  • 1 location
Featured trial
Atopic Dermatitis (Eczema) with Chronic Itching

Does chronic itching from eczema have you ready to shed your skin? Management of chronic itching can be frustrating for both patients and physicians. In any instances, the current therapies

  • 19 views
  • 11 Mar, 2021
  • 1 location
Featured trial
Studies for the Treatment of Atopic Dermatitis (eczema)

Studies for the Treatment of Atopic Dermatitis (eczema)

  • 824 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Atopic Dermatitis In Young Adults

Atopic Dermatitis is a chronic medical condition that has increased over the past two to three decades. It affects between 15-30% of children and 2-10% of adults. Local physicians are

  • 48 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Acne, psoriasis, atopic dermatitis

Acne, psoriasis, atopic dermatitis

  • 1950 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).

A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).

  • 468 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Eczema Research Study - Compensation up to $420

  If you have symptoms of eczema such as itchy red patches you may qualify for a Research Study. Qualified participants receive study-related exams, medication and care from a

  • 140 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Tralokinumab monotherapy for moderate to severe atopic dermatitis

Clinical research study for the treatment of moderate to severe atopic dermatitis.

  • 1311 views
  • 07 Nov, 2020
  • 1 location
Featured trial
INCB 18424-303: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE-AD1)

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

atopic dermatitis/eczema
atopic dermatitis
eczema
  • 270 views
  • 25 Aug, 2021
  • 19 locations
Featured trial
INCB 18424-304: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE-AD2) for 304

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

atopic dermatitis
atopic dermatitis/eczema
dermatitis
eczema
  • 379 views
  • 25 Aug, 2021
  • 11 locations